Bladder Cancer - Results from #50

Feasibility and Oncological Outcome of Patients Achieving Noninvasive Downstaging After Transurethral Resection of Bladder Tumor Plus Systemic Chemotherapy for Bladder Preservation Strategy in Muscle-Invasive Bladder Cancer. January 15, 2025

Immediate second resection versus restage transurethral resection of bladder tumor: A prospective randomized clinical trial (IMMERSE trial). January 15, 2025

Gemcitabine and docetaxel for high-risk non-muscle-invasive bladder cancer: EuroGemDoce group results. January 14, 2025

Clinical Outcomes With Immune Checkpoint Inhibitors in Patients With FGFR2/3, MTAP or ERBB2 Genomic Alterations in Advanced Urothelial Carcinoma. January 14, 2025

Treatment of metastatic urothelial carcinoma in the United Kingdom, France, Germany, Italy, and Spain. January 13, 2025

NECTIN-4 PET FOR OPTIMIZING ENFORTUMAB VEDOTIN DOSE-RESPONSE IN UROTHELIAL CARCINOMA. January 13, 2025

Pfizer’s Sasanlimab in Combination with BCG Improves Event-Free Survival in Patients with BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer January 10, 2025

Integrating gene therapy into the treatment paradigm for non-muscle invasive bladder cancer. January 10, 2025

Is There a Role for Surgery in the Treatment of Metastatic Urothelial Carcinoma? January 10, 2025

Outcomes of Bladder-Preserving Radiation Therapy in Locally Advanced MIBC - Expert Commentary January 9, 2025

Towards Reliable Methodology: Microbiome Analysis of Fresh Frozen vs. Formalin-Fixed Paraffin-Embedded Bladder Tissue Samples: A Feasibility Study. January 9, 2025

Sequential Endoluminal Doxorubicin and Gemcitabine Alternating Weekly with Sequential Mitomycin and Docetaxel for Recurrent Non-Muscle Invasive Urothelial Carcinoma. January 9, 2025

PD-L1 expression in high-risk non-muscle invasive bladder cancer is not a biomarker of response to BCG. January 8, 2025

Bowel regimens before radical cystectomy: An analysis of a modern cohort. January 8, 2025

The Molecular Features and Spatial Architecture of Bladder Ewing Sarcoma - Expert Commentary January 7, 2025

Home Urine Dipstick Screening for Bladder and Kidney Cancer in High-Risk Populations in England: A Microsimulation Study of Long-Term Impact and Cost-Effectiveness. January 7, 2025

Patterns of Failure After Definitive Trimodality Therapy for Muscle-Invasive Bladder Cancer. January 7, 2025

Comprehensive genomic characterization of early-stage bladder cancer. January 7, 2025

Single-cell RNA sequencing and spatial transcriptomics of bladder Ewing sarcoma. January 7, 2025

Treatment Patterns for Metastatic Urothelial Carcinoma Across Eight Mexican Centers: The ALEBRIJE Study. January 6, 2025

Page 3 of 528